SCHEMBL9920797

SCHEMBL9920797

Cc1ccc(-c2ccc3c(c2)oc2cc(-c4cc(-c5ccccc5)c5ccc6cc(C(C)(C)C)cc7ccc4c5c67)ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CA12 O43570 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CCNC P24863 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ MAOB P27338 3/20 0.33
▸ GAA P10253 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HSD11B1 P28845 2/20 0.32
▸ HPRT1 P00492 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ ALDH2 P05091 1/20 0.31
▸ AKR1B1 P15121 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ HSD17B3 P37058 1/20 0.31
▸ SORD Q00796 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920795 0.95 ALDH1A1 (0.39) ALDH1A1MAPTCA12CA9MAOB
SCHEMBL9920793 0.93 ALDH1A1 (0.36) ALDH1A1MAPTCA12CA9MAOB
SCHEMBL12380317 0.91 ALDH1A1 (0.38) ALDH1A1MAPTCA12CA9MAOB
SCHEMBL12380308 0.90 MAPT (0.38) ALDH1A1MAPTGAAGPR84MAOA
SCHEMBL12380281 0.90 MAPT (0.36) ALDH1A1MAPTCA12CA9MAOB
SCHEMBL12380324 0.89 ALDH1A1 (0.41) ALDH1A1MAPTCA12CA9MAOB
SCHEMBL12380312 0.87 ALDH1A1 (0.39) ALDH1A1MAPTGPR84MAOAPGR
SCHEMBL12380307 0.87 ALDH1A1 (0.39) ALDH1A1MAPTGPR84MAOAPGR
SCHEMBL12380293 0.86 AHR (0.38) ALDH1A1MAPTMAOBGAAGPR84
SCHEMBL12380334 0.86 ALDH1A1 (0.34) ALDH1A1MAPTCA12CA9MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 — — US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 — — US disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 — — EP disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 — — EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 — — US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 — — US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 ALDH1A1 1929/4885MAPT 3173/4885CA12 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback